In vitro antimicrobial screening of methanolic extracts of Cleome chelidonii and Cleome gynandra

  • Nimmakayala Sridhar Department of Pharmacology, Pydah College of Pharmacy, Kakinada, A.P, India
  • Bondada V.V.S. Surya kiran Department of Pharmaceutical technology, Koringa College of Pharmacy, Korangi, A.P, India
  • Donthamsetti Tharaka Sasidhar Department of Pharmacology, Koringa College of Pharmacy, Korangi, A.P, India
  • Lakshmi Kanta Kanthal Department of Pharmacology, Koringa College of Pharmacy, Korangi, A.P, India
Keywords: Cleome chelidonii, Cleome gynandra, Minimum inhibitory concentration
DOI: 10.3329/bjp.v9i2.17759

Abstract

Antimicrobial activity of methanolic extracts of plants was screened by disc diffusion assay against four bacteria and four fungal cultures. Streptomycin (10 ug/disc) and nystatin (10 μg/disc) are used as standards for bacteria and fungi respectively. Minimum inhibitory concentration (MIC) of the extracts was evaluated through micro broth dilution method. The antimicrobial potency of plant extracts was assessed by their zone of inhibition and activity index values. Total activity of extracts was evaluated to quantitatively compare the activity of two plants. Methanolic extract of Cleome gynandra showed maximum antibacterial activity against Staphylococcus aureus (IZ- 22 ± 0.22 mm, AI- 0.917, MIC- 0.039 mg/mL, MBC- 0.039 mg/mL). Maximum antifungal potential was shown by C. chelidonii against Candida albicans (IZ- 25 ± 0.92 mm, AI-1.000, MIC- 0.039 mg/mL, MFC- 0.039 mg/mL). Both the extracts exhibited good antimicrobial activity with low range of MIC.

Introduction

Many antibacterial agents are available in the market, which are developed by the great scientists. But still the microbes are challenging the scientists by developing the resistance to the presently available drugs. Plants are known to produce a variety of compounds to protect themselves against a variety of their pathogens and therefore considered as potential source for different classes of antimicrobial substances (Sridhar et al., 2012).

Fungal diseases are classified at the fourth range of nosocomial infections. Victims of fungi infections can be found elsewhere in the world, with the predomination in a third of the world's countries (43%). The development of resistance to drug by pathogens and toxic side effects of available antifungal therapies have emphasized the search for new efficient and none or less-toxic antifungal drugs (Bouguerra et al., 2004; Barchiesi et al., 2006; WHO, 1996). Recently, Amberboa divaricata (Iqbal et al., 2014), Artemisia annua (Zhang et al., 2012), Asparagus laricinus (Ntsoelinyane and Mashele, 2014), Asparagus racemosus (Shah et al., 2014), Berberis jaeschkeana (Alamzeb et al., 2013), Buddleja polystachya (Fawzy et al., 2013), Leucas clarkei (Das et al., 2012), Phyllostachys edulis (Shen et al., 2012), Pithecellobium jiringa (Bakar et al., 2012), Rhododendron arboretum (Nisar et al., 2013) and Sarcochlamys pulcherrima (Mazumder et al., 2014) showed antimicrobial activities.

Considering the vast potentiality of plants as sources for antimicrobial drugs with reference to antibacterial and antifungal agents, a systematic investigation was undertaken to screen the antibacterial and antifungal activity of Cleome chelidonii and Cleome gynandra.

Cleome genus represents the species of herbaceous annual or perennial plants and shrubs widely distributed in tropical and subtropical regions. C. chelidonii Linn (Latin name is Polanisia chelidonii) is a perennial plant belonging to the family Capparaceae. It grows as perennials throughout dry seasons. C. chelidonii is generally known to be used for the treatment of colic, dysentery, headache, otitis, and rheumatism (Kirtikar and Basu, 1991). It has also been found to possess multiple therapeutic properties such as its use a vermifuge, the treatment of skin diseases and its anti-inflammatory, antinociceptive, antipyretic properties (Parimalakrishnan et al., 2007) and hepatoprotective activities (Ethadi et al., 2013). C. chelidonii contains glucocapparin and glucocleomin (Songsak et al., 2004).

gynandra L. Syn Gynandropsis pentaphylla DC (Capparidacea) is a common weed, which grows in most tropical countries. In India the common names include hurhur and karaila. The medicinal application of C. gynandra is also described in Ayurvedic pharmacopoeia of India and also in other ancient medical texts. In Ayurvedic medicine it is a chief constituent in Narayana Churna. In Ayurveda it is used as an anthelmentic, in ear diseases, pruritis and several other diseases like gastrointestinal disorders and gastrointestinal infections etc (The Ayurvedic Pharmacopoeia of India, 2007). The leaves and seeds of the plant have long been in use as indigenous medicine for treatment of headaches and stomach aches. Sap from leaves has been used as an analgesic particularly for head ache, epileptic fits and ear ache. A decoction or infusion of boiled leaves and/or roots has been administered to facilitate childbirth. Bruised leaves, which are rubefacent and vesicant, are also used to treat neuralgia, rheumatism and other localized pains (Rastogi et al., 2009). It has also been found to possess anti-inflammatory (Mule et al., 2008), Immunomodulatory (Rastogi et al., 2009), hypoglycemic (Shaik et al., 2013) properties. Plant contains Cleogynol, 5,7-dihydroxychromone, 5-hydroxy-3,7,4-trimethoxyflavone, luteolin, hexacosanol, sitosterol and kaempferol (Das et al., 1999; Gupta et al., 1968; Jain et al., 1999).

Materials and Methods

Plant materials and extraction

Fresh leaves of C. chelidonii and C. gynandra which are free from disease were collected from local areas of Kakinada, Andhra Pradesh, India. The plants are authenticated by Botanical Survey of India, Hyderabad (BSI/DRC/2013-14/Tech./522). The plant leaves were shade dried at room temperature of (32 ± 2)°C and the dried leaves were ground into fine powder using pulverizer. The powdered part was sieved and stored in cellophane bags. The powdered leaves are extracted successively in soxhlet apparatus, using methanol. The extracts were evaporated to dryness and stored at 4°C until used.

Preparation of nutrient agar

The weighed amount of NaCl (5 g), peptone (10 g), Beef extract (10 g) are dissolved in 1, 000 mL of the water, then agar (20 g) is added slowly on heating with continues stirring until agar is completely dissolved and pH is adjusted to 7.2 to 7.4. This nutrient agar medium is then sterilized by moist heat sterilization method using autoclave at temperature of 120°C at 15 lb pressure maintained for 15 min.

Preparation of potato dextrose agar (PDA)

The potato was peeled and 100 g was measured, finely chopped and boiled to a mash in distilled water. The dextrose was measured (12.5 g) and placed in a 1L measuring cylinder. Agar was measured (12.5 g) and added to the measuring cylinder (with the dextrose). The potato mash was stirred and strained into the cylinder. Hot distilled water was added to make up 500 mL. The contents was continuously poured and stirred until consistency was achieved. The content was then poured into a conical flask, plugged with cotton wool, over which aluminum foil was tightly wrapped. The flask was then autoclaved at 121°C for 24 hours (Murray et al., 1995).

Microbial cultures

Bacterial cultures of Gram positive bacteria Bacillus subtilis (MTCC 441), Staphylococcus aureus (MTCC 3160) and Gram–negative bacteria Escherichia coli (MTCC 46), Pseudomonas aeruginosa (MTCC 1688) and fungal cultures of Aspergillus flavus (MTCC 277), Aspergillus niger (MTCC 2723), Candida albicans (MTCC 183), Fusarium axisporum (MTCC 1755) were procured from Institute of Microbial Technology, Chandigarh, Punjab, India.

Antimicrobial activity

Plant extracts were investigated by the disc diffusion method using 6 mm filter discs (Andrews et al., 2001). Whatmann filter paper (No. 1) discs of 6 mm diameter were made by punching the paper and the blank discs were sterilized in hot air oven at 160°C for one hour. Then the sterile filter paper discs were impregnated with 50 uL and 100uL of 10 mg/mL solution of each plant extract to give a final concentration of 500 and 1,000 ug/disc. The test discs are left to dry in vacuum so as to remove residual solvent, which might interfere with the experimental result. Nutrient agar and potato dextrose agar base plates were seeded with the bacterial and fungal inoculums, respectively with inoculums size 1 x 108 CFU/mL for bacteria and 1 x 107 cell/mL for fungi (Baker et al., 1983). The impregnated discs with extracts were then planted at equidistant points on top of the inoculated agar medium by sterile forceps. Each extract was tested in triplicate with streptomycin (10 ug/disc) and nystatin (10 ug/disc) as standards for bacteria and fungi, respectively. The plates were kept at 4°C for 1 hour for diffusion of extract, thereafter were incubated at 37°C for bacteria (24 hours) and 28°C for fungi (48 hours). At the end of the incubation period the antimicrobial activity was evaluated by measuring the average of inhibition zones using digital vernier caliper (including disc diameter of 6 mm). Activity index for each extract was calculated by using following formula.

Activity index (AI) = Inhibition zone of the sample/Inhibition zone of the standard

Determination of Minimal Inhibitory Concentration (MIC) and Minimum Bactericidal/Fungicidal Concentration (MBC/MFC)

MIC is the concentration required to inhibit growth of a specific isolate in vitro under standardized conditions. The MIC, MBC and MFC were performed by a serial dilution technique using 96-well microtiter plates (Barsi et al., 2005). Plant extracts were resuspended in acetone (which has no activity against test microorganisms) to make 10 mg/mL final concentration and then two fold serially diluted. To measure the MIC values, various concentrations of the stock, 10, 5, 2.5, 1.25, 0.625, 0.312, 0.156, 0.078, 0.039, 0.019 mg/mL were assayed against the test pathogens. 1 mL of each extract was added to test tubes containing 1 mL of sterile Nutrient agar media (for bacteria) Potato dextrose agar media (for fungi). The tubes were then inoculated with standard size of microbial suspension (for bacteria 1 x 108 CFU/mL and 1 x 107 cell/mL for fungi) and the tubes were incubated at 37°C for 24 hours for bacteria and 28°C for 48 hours for fungi in a BOD incubator and observed for change in turbidity after 24 hours and compared with the growth in controls. A tube containing nutrient broth and inoculums but no extract was taken as control. Bacterial and fungal suspensions were used as negative control, while broth containing standard drug was used as positive control. Each extract was assayed in duplicate and each time two sets of tubes were prepared, one was kept for incubation while another set was kept at 4°C for comparing the turbidity in the test tubes. The lowest concentration which completely inhibited the microbial growth (no turbidity) was recorded as MIC (mg/mL). The turbidity was measured by ELISA micro plate reader (Biotech USA) at 540 nm and the growth was indicated if OD value that increased twice its initial value. The MBC/MFC was determined by subculturing 50 uL from each well. Least concentration of extract showing no visible growth on subculturing was taken as MBC/MFC (Singh et al., 2013).

Total activity determination

Total activity is the volume at which the test extract can be diluted with the ability to kill microorganisms. It is calculated by dividing the amount of extract from 1 g plant material by the MIC of the same extract or compound isolated and is expressed in mL/g (Eloff, 2004).

Total activity = Extract per gram dried plant part/MIC of extract.

Result and Discussion

The antimicrobial potency of methanolic extracts of the two plants C. chelidonii and C. gynandra were assessed by their zone of inhibition (IZ) and activity index (AI) values which reveals that these two plant shows significant antimicrobial effects compared to standards (Figure 1).

Figure 1: Comparative antimicrobial activity of plant extracts

Methanolic extract of C. gynandra showed maximum antibacterial activity on Staphylococcus aureus (IZ- 22 ± 0.22 mm, AI-0.917, MIC- 0.039 mg/mL, MBC- 0.039 mg/mL) followed by Bacillus subtilis (IZ- 21 ± 0.52 mm, AI-0.875, MIC- 0.078 mg/mL, MBC- 0.078 mg/mL). Methanolic extract of C. chelidonii showed maximum antibacterial activity on Staphylococcus aureus (IZ- 21 ± 0.16 mm, AI-0.875, MIC- 0.078 mg/mL, MBC- 0.078 mg/mL) followed by Pseudomonas aeruginosa (IZ- 18 ± 0.26 mm, AI-0.857, MIC- 0.156 mg/mL, MBC- 0.312 mg/mL). Maximum antifungal potential of C. chelidonii was observed against Candida albicans (IZ- 25 ± 0.92 mm, AI-1.000, MIC- 0.039 mg/mL, MFC- 0.039 mg/mL) followed by Aspergillus niger (IZ- 22± 0.66 mm, AI-0.956, MIC- 0.078 mg/mL, MFC- 0.078 mg/mL). C. gynandra shows maximum antifungal potential against Candida albicans (IZ- 24 ± 0.18 mm, AI- 0.960, MIC- 0.039 mg/ mL, MFC- 0.078 mg/mL) followed by Aspergillus niger (IZ- 22 ± 0.24 mm, AI-0.956, MIC- 0.078 mg/mL, MFC- 0.156 mg/mL). Both the plants showed maximum effects on fungi than that of bacteria (Table I and II). Fungi and Gram-positive bacteria are found to be more susceptible to the extracts and Gram-negative bacteria are intermediately susceptible. Gram-positive bacteria was found to be the most susceptible organism than Gram-negative bacteria to the plant extracts  which may be due to difference in cell wall structural between these classes of bacteria. C. gynandra showed more antibacterial activity compared to that of C. chelidonii and C. chelidonii showed more antifungal activity compared to that of C. gynandra.

Table I: Antibacterial activity of C. chelidonii and C. gynandra

  Extract concentration (ug/disc) Test microorganism
Pseudomonas aeruginosa
IZ (mm) AI IZ (mm) AI IZ (mm) AI IZ (mm) AI
Streptomycin 10 24 ± 0.2 - 24 ± 0.2 - 22 ± 0.3 - 21 ± 0.2 -
C. chelidonii 500 15 ± 0.7 0.6 18 ± 0.4 0.8 12 ± 0.4 0.5 12 ± 0.2 0.6
C. chelidonii 1000 20 ± 0.2 0.8 21 ± 0.2 0.9 18 ± 0.7 0.8 18 ± 0.3 0.9
C. gynandra 500 16 ± 0.2 0.7 18 ± 0.8 0.8 12 ± 0.3 0.5 11 ± 0.5 0.5
C. gynandra 1000 21 ± 0.5 0.9 22 ± 0.2 0.9 17 ± 0.2 0.8 16 ± 0.2 0.8
IZ of negative control for each bacteria is 0.0 mm. Values are mean ± SEM; n = 3, (p>0.05)

Table II: Antifungal activity of C. chelidonii and C. gynandra

  Extract concentration (ug/disc) Test microorganism
Aspergillus flavus
IZ (mm) AI IZ (mm) AI IZ (mm) AI IZ (mm) AI
Nystatin 10 22 ± 0.6 - 23 ± 0.1 - 25 ± 0.1 - 22 ± 0.4 -
C. chelidonii 500 15 ± 0.3 0.7 18 ± 0.4 0.8 19 ± 0.5 0.8 14 ± 0.2 0.6
C. chelidonii 1000 21 ± 0.2 1.0 22 ± 0.7 1.0 25 ± 0.9 1.0 21 ± 0.3 1.0
C. gynandra 500 15 ± 0.3 0.7 17 ± 0.4 0.7 19 ± 0.3 0.8 13 ± 0.3 0.6
C. gynandra 1000 21 ± 0.3 1.0 22 ± 0.2 1.0 24 ± 0.2 1.0 19 ± 0.2 0.9
IZ of negative control for each fungus is 0.0 mm. Values are Mean ± SEM; n = 3, (p>0.05)

MIC and MBC/MFC values (Table III and IV) were recorded for the plant extracts. The lowest MIC values were recorded for C. chelidonii against Candida albicans (0.039 mg/mL) and for C. gynandra against Staphylococcus aureus (0.039 mg/mL) and Candida albicans (0.039 mg/mL). These low MIC values suggesting the more susceptible nature of these organisms towards the plant extracts and supporting the AI values obtained in the assay. Higher values of MBC/MFC than that of MIC indicated that bacteriostatic/fungistatic nature of the extracts, which were observed for the active extracts.

Table III: MIC and MBC values (mg/mL) of plant C. chelidonii and C. Gynandra

Plant Test microorganism
Bacillus subtilis Staphylococcus aureus Escherichia coli Pseudomonas aeruginosa
MIC MBC MIC MBC MIC MBC MIC MBC
C. chelidonii 0.078 0.156 0.078 0.078 0.156 0.312 0.156 0.312
C. gynandra 0.078 0.078 0.039 0.039 0.156 0.625 0.625 1.250

Table IV: MIC and MFC values (mg/mL) of C. chelidonii and C. gynandra

Plant Test microorganism
Aspergillus flavus Aspergillus niger Candida albicans Fusarium axisporum
MIC MFC MIC MFC MIC MFC MIC MFC
C. chelidonii 0.078 0.156 0.078 0.078 0.039 0.039 0.156 0.312
C. gynandra 0.078 0.156 0.078 0.156 0.039 0.078 0.312 0.312

Total activity and quantity of extracts from each plant was calculated and recorded (Table V). Total activity indicates the volume at which extract can be diluted which still having ability to kill microorganism. Both the extracts showed high total activity values against Candida albicans (2394.9 mL/g). C. gynandra showed high total activity values against Staphylococcus aureus (2394.9 mL/g) compared to other bacterial culture. These total activity values indicating the potential of plant extracts to inhibit growth of the test microorganisms even at low concentration. The two plant extracts inhibited the growth of selected bacteria and fungi, indicating broad spectrum bioactive nature of plants.

Table V: Total activity (TA) of C. chelidonii and C. gynandra extracts

  Total activity of microorganisms (mL/g)
Amount (mg/g) Bacillus subtilis Staphylococcus aureus Escherichia coli Pseudomonas aeruginosa Aspergillus flavus Aspergillus niger Candida albicans Fusarium axisporum
C. chelidonii 81.6 1046.2 1046.2 523.1 523.1 1046.2 1046.2 2092.3 523.1
C. gynandra 93.4 1197.4 2394.9 598.7 149.4 1197.4 1197.4 2394.9 299.4

Plants are reservoirs of blockbuster molecule which can be used as antimicrobial agents. Plant based new antimicrobials have enormous therapeutic potential as the microbes are developing resistance towards the currently available antibiotics. Keeping this as research envisage the present screening was done and we got significant results to prove the traditional medicinal plants C. chelidonii and C. gynandra are having good antimicrobial properties.

Conclusion

Based on our results, it can be concluded that methanol leaf extract of C. chelidonii and C. gynandra possess significant antibacterial and antifungal activity, hence it can be further exploited for developing safe and potent antimicrobials.

References

Alamzeb M, Khan MR, Ali S, Shah SQ, Rashid MU. Antimicrobial properties of extracts and compounds isolated from Berberis jaeschkeana. Bangladesh J Pharmacol. 2013; 8: 107-09.

Andrews JM, BSAC Working party on susceptibility testing ft. BASC standardized disc susceptibility testing method. J Antimicrob Chemother. 2001; 4: 43-57.

Baker CN, Thornsberg CH. Inoculum standardization in antimicrobial susceptibility tests: Evaluation of overnight age culture. J Chin Microbiol. 1983; 17: 140-57.

Bakar RA, Ahmad I, Sulaiman SF. Effect of Pithecellobium jiringa as antimicrobial agent. Bangladesh J Pharmacol. 2012; 7: 131-34.

Barchiesi F, Spreghini E, Tomassetti S, Della AV, Arzeni D, Manso E, Scalise G. Effects of Caspo fungin against Candida guilliermondii and Candida parapsilosis. Antimicrob Agents Chemother. 2006; 50: 2719–27.

Barsi DF, Fan SH. The potential of aqueous and acetone extracts of galls of Quercus infectoria as antibacterial agents. Indian J Pharmacol. 2005; 37: 26-29.

Bouguerra R, Essaïs O, Sebaï N, Ben Salem L, Amari H, Kammoun MR, Chaker E, Zidi B, Ben Slama C. 2004. Prévalence et aspects cliniques des mycoses superficielles chez le diabétique tunisien en milieu hospitalier. Flavour Fragrance J. 2004; 18: 210-15.

Das PC, Patra A, Mandal S, Mallick B, Das A, Chatterjee A. Cleogynol, a novel dammarane triterpenoid from Cleome gynandra. J Nat Prod. 1999; 62: 616-18.

Das SN, Patro VJ, Dinda SC. Antimicrobial activity of Leucas clarkei. Bangladesh J Pharmacol. 2012; 7: 135-39.

Eloff JN. Quantifying the bioactivity of the plant extracts during screening and bioassay guided fractionation.

Phytomedicine 2004; 11: 370-71.

Ethadi S, Pragada R, Battu G. Evolution of anti-inflammatory and hepatoprotective activities of different extracts of Cleome chelidonii root in albino rats. Int J Pharma Biosci. 2013; 4: 111 -19.

Fawzy GA, Gamal AAE, Ati HYA. Antimicrobial and cytotoxic potentials of Buddleja polystachya extracts. Bangladesh J Pharmacol. 2013; 8: 136-41.

Gupta RK, Chandra S, Mahadevan V. Chemical examination of the seed of Gynandropsis petaphylla. Indian J Pharm. 1968; 30: 127-28.

Iqbal SM, Mushtaq A, Jabeen Q. Antimicrobial, antioxidant and calcium channel blocking activities of Amberboa divaricata. Bangladesh J Pharmacol. 2014; 9: 29-36.

Jain AC, Gupta SM. Minor phenolic components of the seeds of Gynandropsis gynandra. J Nat Prod. 1985; 48: 332-33.

Kirtikar KR, Basu BD. In: Indian medicinal plants, Vol. 1. 2nd ed. Delhi, Periodical Experts Book Agency, 1991.

Mazumder AH, Das J, Gogoi HK, Chattopadhyay P, Paul SB. Antimicrobial activity of methanol extract and fractions from Sarcochlamys pulcherrima. Bangladesh J Pharmacol. 2014; 9: 4-9.

Mule SN, Patil SB, Naikwade NS, Magdum CS. Evaluation of antinociceptive and anti-inflammatory activity of stems of Gynandropsis pentaphylla Linn. Int J Green Pharm. 2008; 2: 87-90.

Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolke RH. Manual of clinical microbiology. 6th ed. London, Mosby Year Book, 1995.

Nisar M, Ali S, Qaisar M, Gilani SN, Shah MR, Khan I, Ali G. Antifungal activity of bioactive constituents and bark extracts of Rhododendron arboretum. Bangladesh J Pharmacol. 2013; 8: 218-22.

Ntsoelinyane PMAH, Mashele S. Phytochemical screening, antibacterial and antioxidant activities of Asparagus laricinus leaf and stem extracts. Bangladesh J Pharmacol. 2014; 9: 10-14.

Parimalakrishnan S, Dey A, Smith A, Manavalan R. Evaluation of anti-inflammatory, antinociceptive and antipyretic effects of methanol extract of Cleome chelidonii. Int J Biol Chem Sci. 2007; 1: 223-28.

Rastogi B, Tiwari U, Dubey A, Bawra B, Nandini D, Chauhan NS, Saraf DK. Immunomodulating activity of Cleome gynandra. Pharmacologyonline 2009; 2: 151-69.

Shah MA, Abdullah SM, Khan MA, Nasar G, Saba I. Antibacterial activity of chemical constituents isolated from Asparagus racemosus. Bangladesh J Pharmacol. 2014; 9: 1-3.

Shaik K, Shaik A, Kumar D, Kadirvel D. Evaluation of preliminary phytochemical properties and hypoglycemic activities of Cleome gynandra L. Int J Pharm Pharmaceut Sci. 2013; 5: 824-28.

Shen X, Zheng D, Gao J, Hou C. Isolation and evaluation of endophytic fungi with antimicrobial ability from Phyllostachys edulis. Bangladesh J Pharmacol. 2012; 7: 249-57.

Singh G, Kumar P. Phytochemical study and screening for antimicrobial activity of flavonoids of Euphorbia hirta. Int J Appl Basic Med Res. 2013; 3: 111-16.

Songsak T, Lockwood GB. Production of two volatile glucosenolate hydrolysis compounds in Nasturtium montanum and Cleome chelidonii plant cell cultures. Fitoterapia 204; 75: 296-301.

The Ayurvedic Pharmacopoeia of India. Part 1. Vol 1. 2007, p 13.

Sridhar N, Kumar NVSP, Sasidhar D, Venkatesh AK, Kanthal LK. Antibactirial and phytochemical evaluation of Oldenlandia biflora L. and Pergularia daemia. Int J Drug Dev Res. 2012; 4: 148-52.

Zhang H, Bai X, Wu B. Evaluation of antimicrobial activities of extracts of endophytic fungi from Artemisia annua. Bangladesh J Pharmacol. 2012; 7: 120-23.

Published
2014-03-30

Apply citation style format of Bangladesh Journal of Pharmacology

Section
Research Articles
Financial Support
Self-funded
Conflict of Interest
Authors declare no conflict of interest.